InnoSpring
Overview
InnoSpring is a venture capital firm founded in 2012 that also operates as an accelerator and incubator, specializing in seed, early-stage, and later-stage investments. The firm focuses on companies in the United States and China within sectors including consumer technology, enterprise software, health technology, and financial technology.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| APstem Therapeutics | Sep 2020 | Seed | Co-investor |
| Shanghai Jikai Gene Medical Technology Co., Ltd. | Mar 2020 | Series C | Co-investor |
| Relay Robotics | Apr 2014 | Seed | Co-investor |
| Chewse | Apr 2013 | Seed | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is InnoSpring based?
InnoSpring is headquartered in Shanghai, California, China.
When was InnoSpring founded?
InnoSpring was founded in 2012.
How many portfolio companies does InnoSpring have?
InnoSpring has 4 portfolio companies in Caplight's dataset.
What are some companies in InnoSpring's portfolio?
Recent investments visible on Caplight include APstem Therapeutics, Shanghai Jikai Gene Medical Technology Co., Ltd., Relay Robotics, Chewse.
What was InnoSpring's most recent investment?
InnoSpring's most recent investment on Caplight was in APstem Therapeutics in 2020.
What sectors does InnoSpring focus on?
InnoSpring focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Consumer & Commerce, Mobility, Transportation & Logistics, Enterprise Software.
What company stages does InnoSpring focus on?
Stage focus information for InnoSpring is not publicly available.
What is InnoSpring's AUM?
InnoSpring's assets under management are estimated between $0.0 and $50.0M.